# LIDOCAINE
> **ANDA217117** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2024-06-18
## Drug
- **FDA Application Number:** ANDA217117
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LIDOCAINE
- **Generic name:** LIDOCAINE
- **Active ingredients:** LIDOCAINE
- **Dosage form:** OINTMENT
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA LTD
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2024-06-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217117)
---
*MORVS · CC0 1.0*